about
Secondary outcomes of a pilot randomized trial of azithromycin treatment for asthmaThe sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanismInfection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides.Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma.What determines asthma phenotype? Respiratory infections and asthma.Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease.Chlamydia pneumoniae and severity of asthma.Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice.Chlamydia pneumoniae infections in asthma: clinical implications.On roots of childhood asthma: the role of respiratory infections.Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis?Comparative analysis of the growth and biological activity of a respiratory and atheroma isolate of Chlamydia pneumoniae reveals strain-dependent differences in inflammatory activity and innate immune evasion.Unusual asthma syndromes and their managementGlucocorticoids increase in vitro and in vivo activities of antibiotics against Chlamydophila pneumoniae.Serological Evidence of Chronic Chlamydia pneumoniae Infection in Coronary Artery Disease.Usefulness of sparfloxacin against Chlamydia pneumoniae infection in patients with bronchial asthma.Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.Atypical pathogen infection in adults with acute exacerbation of bronchial asthma.Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae.Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma.Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae.Asthma, atopy and Chlamydia pneumoniae antibodies in adults.Chlamydophila pneumoniae enhances secretion of VEGF, TGF-beta and TIMP-1 from human bronchial epithelial cells under Th2 dominant microenvironment.Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities.Atypical bacteria and macrolides in asthmaIs Chlamydia pneumoniae important in asthma? The first controlled trial of therapy leaves the question unanswered.
P2860
Q21563468-19D999E8-73A5-4565-BB66-29AFAF58B84CQ27333845-3C5860D4-1837-4FE6-B7D8-FB20F08CE32CQ33706917-C361B1EF-726A-496E-9745-6371674A0C23Q33726287-CEC4A197-2404-46FC-9246-227D398A08C2Q33860308-186F1751-FC32-4986-9222-E80A06B9B499Q33889878-AD148015-D4A3-459A-BD17-21C91C411BCBQ34116681-636A4147-57B8-4064-939C-4E322700B2CDQ34716041-2C54EFCB-2275-48D7-96EB-882A3609B768Q35627745-3F4711B6-3FFF-45F0-B9EA-D9FE9F7C9F61Q36132283-5ACF98ED-6801-476F-97B8-D2ECB4E54B89Q36165742-46A4AC2B-9E8E-4EE7-BAEF-5184439CF4CCQ36202987-6E015A56-35A9-4EF9-BE69-52E248F38092Q36443760-5DB74183-6A59-4C1A-BD99-D6074354E11AQ37624924-BB0A9E5D-E140-4E10-8C6E-2B1DAE97DF3DQ37859518-5B88FEDD-BCA8-4ACC-BDAE-8EDE4EA8FA63Q37863292-B88AA68D-F359-476F-942D-869F5C76207BQ37867383-74445737-5F5A-43C9-919A-64A58C995518Q37870844-C5C9F75C-8120-4A93-B909-49855B258A73Q37873600-622FB16B-3E2A-4E5E-A749-B43A3611B1A3Q37874359-757852BC-1621-4828-88BB-775E3DDD15BBQ37876556-BE2640A6-5216-4787-A8F7-1297FE379052Q37878633-CB5C6284-B658-4C01-B01A-EF8B466F925FQ38487699-8E51CA61-D25C-428E-AE0B-B73D9BEF224EQ39267966-D8CD5CD0-9A74-4646-8F52-FDB6E186A864Q40518030-8EC42DE2-7AD3-4288-A2D9-4D10C0D317F9Q43424830-B2CCE346-4956-40EE-8477-882080BF4F4A
P2860
description
1998 nî lūn-bûn
@nan
1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Chlamydia pneumoniae and asthma
@ast
Chlamydia pneumoniae and asthma
@en
type
label
Chlamydia pneumoniae and asthma
@ast
Chlamydia pneumoniae and asthma
@en
prefLabel
Chlamydia pneumoniae and asthma
@ast
Chlamydia pneumoniae and asthma
@en
P2093
P2860
P356
P1433
P1476
Chlamydia pneumoniae and asthma
@en
P2093
P2860
P304
P356
10.1136/THX.53.4.254
P407
P577
1998-04-01T00:00:00Z